<DOC>
	<DOCNO>NCT02918370</DOCNO>
	<brief_summary>The investigator conduct 12-week , randomize , double-blind , parallel-group , placebo-controlled study aripiprazole 132 person Alcohol Use Disorder ( AUD ) bipolar I II disorder , currently depress mixed phase . Primary Aim ass change alcohol use Timeline Followback ( TLFB ) method . Secondary Aim include change alcohol crave use Penn Alcohol Craving Scale ( PACS ) . Changes psychiatric symptom ( mania/hypomania depression ) predictor response assess . Participants â‰¥ 1 drinking day week 12 enrol 4-week extension phase upward titration 30 mg/day active treatment group . The placebo group remain placebo . Subjects discontinue study follow condition occurs : change diagnosis bipolar I II disorder AUD , development active suicidal homicidal ideation plan intent , worsen mood symptom , opinion investigator require discontinuation , pregnancy , development severe life-threatening medical condition , involuntary psychiatric hospitalization incarceration , significant alcohol withdrawal ( e.g . delirium tremens ) base clinical judgment ( increase Clinical Institute Withdrawal Assessment Alcohol ( CIWA-Ar ) score initiate careful clinical assessment possible worsening withdrawal symptom ) , cocaine amphetamine-positive urine drug screen study .</brief_summary>
	<brief_title>Aripiprazole Bipolar Disorder Alcohol Use Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Outpatient men woman age 1865 year old bipolar I , II , Not Otherwise Specified ( NOS ) disorder Current Diagnosis Alcohol Use Disorder Current Alcohol use Current mood stabilizer therapy stable dose &gt; 28 day Fluent English Spanish Baseline Hamilton Rating Scale Depression ( HRSD ) Young Mania Rating Scale ( YMRS ) score &gt; 35 Evidence clinically significant alcohol withdrawal symptom Current treatment atypical antipsychotic Current treatment naltrexone , acamprosate , disulfiram , topiramate last 28 day Prior treatment Aripiprazole within last year lifetime history intolerable side effect Aripiprazole Vulnerable population ( e.g . pregnant , nursing , cognitively impaired , incarcerated . ) High risk suicide Aspartate Amino Transferase ( AST ) Alanine Amino Transferase ( ALT ) &gt; 3 time upper limit normal Current use Cytochrome P450 3A4 enzyme induce medication ( e.g . carbamazepine , rifabutin , rifampin , ritonavir . ) More specific inclusion exclusion criterion discuss participant baseline assessment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Alcohol Use Disorder</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Mood</keyword>
	<keyword>Alcohol Craving</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>